Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

Delayed Data
As of Mar 22
 -1.05 / -5.59%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 18.00 and a low estimate of 10.00. The median estimate represents a -9.86% decrease from the last price of 17.75.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Hold stock in Momenta Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -347.22%
Growthannually -0.13%


Growthquarterly -75.09%
Growthannually -17.27%
Key to the earnings and sales forecast charts.